Interojo Co

Interojo Co Net Margin

The Net Profit Margin of Interojo Co (119610.KQ) as of Nov 20, 2026 is 10.92 %. In the previous year, Net Profit Margin was 0.16 % — a change of 6,764.61% (higher).

Net Margin

10.92 %

YoY

6,764.61%

Last updated:

Net Profit Margin of Interojo Co is 2025 10.92 % . Net Profit Margin of Interojo Co was 2024 0.16 % . It decreases by 6,764.61% higher compared to the previous year.

Interojo Co's net margin stands at 10.9%, down from 16.3% several years earlier.

The Interojo Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
18.38 KRW
Jan 1, 2019
18.96 KRW
Jan 1, 2020
13.09 KRW
Jan 1, 2021
16.30 KRW
Jan 1, 2022
19.06 KRW
Jan 1, 2023
2.65 KRW
Jan 1, 2024
0.16 KRW
Jan 1, 2025
10.92 KRW
The Interojo Co Net Margin history
YEARNet MarginYoY
10.92 %+6,764.61%
0.16 %-93.99%
2.65 %-86.10%
19.06 %+16.90%
16.30 %+24.57%
13.09 %-30.99%
18.96 %+3.19%
18.38 %-23.13%
23.91 %-8.91%
26.25 %+24.13%
21.14 %+30.48%
16.21 %+7,099.65%
0.23 %-21.82%
0.29 %+3.13%
0.28 %-2.08%
0.29 %-23.56%
0.37 %+100.82%
0.19 %+56.07%
0.12 %-32.06%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Net Profit Margin of Interojo Co is 10.92 % in 2025.

Net Profit Margin of Interojo Co changed from 0.16 % to 10.92 %, representing a 6,764.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Interojo Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Interojo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Interojo Co

All Key Metrics — Interojo Co